Skip to main content

Table 4 Univariate and multivariable analysis for phlebitis using marginal Cox regression analysis for phlebitis

From: Risk factors for peripheral intravascular catheter-related phlebitis in critically ill patients: analysis of 3429 catheters from 23 Japanese intensive care units

Variables

Univariable analysis

N = 3429

Phlebitis: 313 (9.1%)

Multivariable analysis

N = 2460

Phlebitis: 247 (10.0%)

HR (95% CI)

p value

HR (95% CI)

p value

ICU characteristics

 Drug administration standardization

0.36 (0.20–0.66)

0.0009

0.35 (0.17–0.76)

0.007

 Education on venous catheter management for nurses

1.29 (1.03–1.63)

0.03

1.15 (0.86–1.54)

0.35

Patient characteristics

 Age

1.01 (0.99–1.01)

0.15

1.01 (0.99–1.02)

0.28

 Gender, male

0.69 (0.55–0.86)

0.0009

0.85 (0.64–1.12)

0.24

 BMI

    

  16–22

Ref.

-

Ref.

-

  ≤15

1.14 (0.45–2.90)

0.78

1.18 (0.60–2.33)

0.62

  23–29

0.95 (0.62–1.46)

0.83

0.86 (0.65–1.14)

0.29

  30≤

0.58 (0.14–2.38)

0.45

0.43 (0.20–0.95)

0.04

 APACHE II

    

  16–25

Ref.

–

Ref.

–

  ≤15

1.09 (0.85–1.39)

0.49

1.07 (0.79–1.45)

0.65

  25 < 

0.77 (0.56–1.05)

0.10

0.70 (0.48–1.01)

0.06

Catheter characteristics

    

 Catheter inserted by (n,%)

    

  Nurse

Ref.

–

Ref.

–

  Doctor

0.55 (0.35–0.86)

0.009

0.55 (0.32–0.94)

0.03

 Number of trials for insertion (n,%)

    

  1

Ref.

–

Ref.

–

  2

0.90 (0.60–1.34)

0.59

1.01 (0.67–1.53)

0.95

  3

1.44 (0.89–2.32)

0.14

1.35 (0.81–2.24)

0.25

  ≥4

0.84 (0.35–2.04)

0.70

1.34 (0.54–3.33)

0.53

 Use of ultrasonography

0.51 (0.19–1.38)

0.19

0.78 (0.24–2.56)

0.68

 Inserted site

    

  Forearm

Ref.

 

Ref.

 

  Upper arm

0.61 (0.39–0.95)

0.03

0.52 (0.32–0.85)

0.009

  Elbow

0.84 (0.50–1.43)

0.53

0.95 (0.50–1.79)

0.87

  Wrist

0.70 (0.38–1.28)

0.24

0.56 (0.26–1.21)

0.14

  Hand

0.58 (0.40–0.84)

0.004

0.67 (0.43–1.04)

0.08

  Lower leg

0.87 (0.56–1.34)

0.52

0.74 (0.46–1.21)

0.23

  Dorsal foot

0.96 (0.58–1.57)

0.86

0.95 (0.55–1.66)

0.87

 Catheter size

    

  22–24G

Ref.

 

Ref.

 

  ≥18G

0.99 (0.60–1.61)

0.96

1.97 (0.68–5.77)

0.21

  20G

0.59 (0.44–0.79)

0.0004

0.75 (0.52–1.08)

0.12

 Dressing

    

  Sterile dressing

Ref.

 

Ref.

 

  Non-sterile dressing

1.36 (0.70–2.64)

0.36

0.90 (0.28–2.89)

0.86

 Catheter material

    

  Polyurethane

Ref.

 

Ref.

 

  PEU-Vialon*

0.61 (0.46–0.81)

0.0007

0.70 (0.49–1.02)

0.06

  Tetrafluoroethylene

0.84 (0.64–1.09)

0.18

0.99 (0.71–1.38)

0.95

  Others

1.37 (0.72–2.62)

0.34

0.94 (0.21–4.16)

0.93

  Infection during catheter dwell

1.10 (0.86–1.40)

0.47

1.36 (0.99–1.85)

0.06

Drug characteristics

 Fentanyl (n, %)

0.89 (0.65–1.21)

0.45

0.81 (0.54–1.21)

0.29

 Heparin

0.62 (0.42–0.92)

0.02

0.65 (0.40–1.07)

0.09

 Fat

1.89 (1.04–3.41)

0.04

0.67 (0.40–1.10)

0.11

 Nicardipine

1.97 (1.46–2.65)

 < 0.0001

1.85 (1.29–2.66)

0.0008

 Dexmedetomidine

1.16 (0.83–1.61)

0.38

1.08 (0.72–1.63)

0.70

 Ampicillin/sulbactam

1.00 (0.63–1.57)

0.99

0.79 (0.47–1.31)

0.36

 Albumin

0.87 (0.44–1.71)

0.68

1.36 (0.82–2.23)

0.23

 Paracetamol

0.63 (0.34–1.18)

0.15

0.69 (0.33–1.46)

0.33

 Potassium

1.62 (1.08–2.42)

0.02

1.32 (0.79–2.21)

0.30

 Meropenem

0.76 (0.46–1.26)

0.28

0.99 (0.52–1.87)

0.96

 Steroid

0.62 (0.32–1.20)

0.16

0.68 (0.32–1.43)

0.31

 Ceftriaxone

0.88 (0.51–1.54)

0.66

0.69 (0.37–1.31)

0.26

 Vancomycin

0.42 (0.20–0.87)

0.02

0.43 (0.18–1.03)

0.06

 Magnesium

0.98 (0.54–1.79)

0.95

0.68 (0.27–1.69)

0.40

 PPN

0.90 (0.48–1.69)

0.74

0.78 (0.37–1.62)

0.50

 Phosphorus

1.30 (0.73–2.31)

0.38

1.11 (0.53–2.33)

0.79

 Noradrenaline

2.54 (1.60–4.04)

 < 0.0001

2.42 (1.40–4.20)

0.002

 Carperitide

1.13 (0.64–2.02)

0.67

0.93 (0.46–1.84)

0.83

 Midazolam

1.63 (0.92–2.91)

0.10

1.50 (0.72–3.11)

0.28

 Nitroglycerin

0.73 (0.32–1.63)

0.44

0.22 (0.05–0.92)

0.04

 Dobutamine

1.54 (0.73–3.26)

0.26

1.14 (0.48–2.68)

0.77

 Cefmetazole

1.20 (0.45–3.22)

0.72

0.92 (0.22–3.82)

0.90

 Amiodarone

2.34 (1.21–4.55)

0.01

3.67 (1.75–7.71)

0.0006

 Cefepime

0.58 (0.22–1.56)

0.28

0.70 (0.25–1.96)

0.49

 Levetiracetam

1.54 (0.21–11.1)

0.67

5.65 (2.80–11.4)

 < 0.0001

 Landiolol

0.75 (0.28–2.00)

0.56

0.73 (0.23–2.38)

0.61

  1. Akaike’s information criterion, 3476.5
  2. APACHE Acute Physiology And Chronic Health Evaluation, BMI body mass index, CI confidence interval, ICU intensive care unit, HR hazard ratio, PPN peripheral parenteral nutrition